ZEMBRILIO
Live / Registered — Registered (as of 21 Jan 2025)
What this means for you
Registered since 21 Jan 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Jan 2031: the §71 affidavit of use).
Record
- Serial number
- 79401730
- Registration number
- 7656812
- Mark type
- Word mark
- Filed
- 11 Jun 2024
- Published for opposition
- 03 Dec 2024
- Registered
- 21 Jan 2025
- Next maintenance filing
- §71 affidavit of use, due by 21 Jan 2031 (grace period to 21 Jul 2031)
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension.
Owner
- Novo Nordisk A/S, DK
- Novo Nordisk A/S, DK
- Novo Nordisk A/S, DK
Prosecution history
- 22 Jan 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 07 Jan 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 07 Jan 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 20 Feb 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 21 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Dec 2024 — PUBLISHED FOR OPPOSITION
- 27 Nov 2024 — NOTICE OF PUBLICATION
- 06 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Nov 2024 — ASSIGNED TO EXAMINER
- 19 Aug 2024 — APPLICATION FILING RECEIPT MAILED
- 19 Aug 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 08 Aug 2024 — SN ASSIGNED FOR SECT 66A APPL FROM IB